Key Highlights

  • GLRE reported third-quarter 2026 Net Income of $3.2 million, or $0.10 per diluted share, versus a $4.4 million loss a year earlier.
  • Net Underwriting income fell to $14.6 million from $22.3 million as the combined ratio rose to 90.5%.
  • Total Investment loss narrowed to $4.6 million from $17.4 million.
  • Fully diluted Book Value per share rose 0.8% from June 30 to $20.78.
  • The company repurchased 1,606,894 ordinary shares for $27.2 million in the first nine months of 2026.

Narrower Investment Loss Turns a $4.4 Million Deficit Into a $3.2 Million Profit

Greenlight Capital Re (NASDAQ:GLRE) disclosed results for the quarter ended Sep 30, 2026 in its quarterly filing dated Nov 2, 2026. Net income was $3.2 million, or $0.10 per diluted share, compared with a net loss of $4.4 million, or $0.13 per share, a year earlier. The swing came mainly from smaller investment losses.

Total investment loss was $4.6 million versus $17.4 million. Gains from partially selling two holdings in the Innovations segment, net of impairments, helped, compared with a $16.5 million Impairment on one investment in 2025. Net investment income was $10.5 million versus a $3.0 million loss, though the Solasglas fund lost $15.1 million, or 3.3%, in the quarter.

Greenlight Capital Re is a Cayman Islands-based specialty property and casualty reinsurer that pairs its underwriting with an investment strategy it considers distinctive.

Combined Ratio Rises to 90.5% as Premiums Shrink and Reserves Turn Adverse

Gross premiums written were $181.9 million, down 1.4%, and net premiums earned fell 7.2% to $153.4 million. Net underwriting income dropped to $14.6 million from $22.3 million, and the combined ratio increased to 90.5% from 86.6%.

Prior-year reserves developed adversely by $2.5 million, against $0.8 million a year ago. The attritional loss ratio climbed to 55.6% from 49.6%, partly offset by a favorable catastrophe and large-event result, as reserves for the Middle East conflict were trimmed to $19 million from $25 million. Nine-month net income was $9.4 million, or $0.28 per share, compared with $25.6 million, or $0.74.

Open Market Contracts 10% While Innovations Premiums Jump 46%

Open Market gross premiums written fell 10% to $138.8 million as certain casualty Quota share programs were not renewed and specialty estimates were revised lower. Its combined ratio was 87.9% versus 84.5%, and the segment cited deteriorating casualty experience and higher expected energy losses. The company described a more competitive market, with pressure on rates and some terms.

Innovations gross premiums written rose 46% to $43.0 million, led by financial and multiline lines. Net premiums earned grew 34% to $28.1 million, and pretax income was $5.8 million versus a $11.3 million loss, though the combined ratio was 98.2%.

Buybacks, a $694.5 Million Equity Base and a Lloyd's Syndicate Upgrade Set the Next Phase

Shareholders' equity was $694.5 million at Sep 30, 2026, against $5.0 million of debt. Basic book value per share was $21.40, and fully diluted book value was $20.78, up from $20.61 in June. Operating Cash Flow for nine months was $73.6 million, versus $110.0 million, and the board authorized a new buyback of up to $40 million running through May 31, 2027.

Syndicate 3456 received approval to become a full Lloyd's syndicate effective Jan 1, 2027, and the company plans to expand Business written through it substantially. At Oct 30, 2026, 32,240,043 ordinary shares were outstanding.